Descrizione Progetto

Premio Salute

2019

Dopo aver conseguito la laurea in Medicina e Chirurgia presso l’Università di Milano nel 1992, si specializza in Cardiologia presso l’Università degli Studi di Milano nel 1997. Nel periodo 1997-1998 svolge una Fellowship in Imaging intracoronarico presso il Washington Hospital Center di Washington, DC. Dal 1998 frequenta il Centro Cardiologico Monzino in qualità di medico assistente presso l’Unità di Cardiologia Interventistica dove diventa Aiuto senior nel 2008 e Referente nel 2014. Nel gennaio 2017 istituisce il Women Heart Center per la prevenzione cardiovascolare nella donna presso il Centro Cardiologico Monzino e da Ottobre 2017 dirige l’Unità Operativa 3 di Cardiologia Invasiva presso il medesimo Istituto.

È Tutor per gli studenti del corso di Medicina e Chirurgia – Università di Milano.

Docente presso la Scuola di Specializzazione in Patologie dell’Apparato Cardiovascolare Università di Milano.

È nominata membro della commissione per la valutazione di dispositivi cardiovascolari presso l’Istituto Superiore di Sanità (2011) e membro della Commissione dell’Istituto Superiore di Sanità (2018) per la stesura del documento ministeriale per l’applicazione e la diffusione della Medicina di Genere (in attuazione dell’articolo 3, comma 1, Legge 3/2018).

Risultati scientifici

L’attività di ricerca di Daniela Trabattoni si concentra soprattutto nell’ambito della Cardiologia Interventistica, indagando i fattori che possono influenzare l’outcome della rivascolarizzazione coronarica in funzione dell’impiego di differenti tipologie di stent coronarici, focalizzandosi anche sull’analisi gender-based. Ha approfondito gli effetti delle terapie di cardioprotezione impiegate nel corso di infarto miocardico acuto quali adiuvanti dell’angioplastica primaria nel recupero funzionale del ventricolo sinistro. Ha esplorato le potenziali correlazioni tra forame ovale pervio e emicrania e condotto analisi comparative tra dispositivi occlusori differenti per la correzione percutanea di PFO. Ha lavorato alla stesura del documento di consenso della società di Cardiologia Invasiva per la gestione della terapia antiaggregante piastrinica in pazienti sottoposti a rivascolarizzazione coronarica e indirizzati a chirurgia in urgenza o elettiva. Ha condotto studi per la valutazione della sicurezza ed efficacia di trattamento antipiastrinico di breve durata dopo impianto di stent coronarici medicati o drug-coated  in pazienti ad alto rischio emorragico.

Ha partecipato a numerosi progetti internazionali.

Acute and 30-day outcomes in women after TAVR: Results from the WIN-TAVI (Women’s International Transcatheter Aortic Valve Implantation) Real World Registry. JACC Cardiovasc Interv2016

Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anesthesiological societies.  Eurointervention, 2014;

Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry. EuroIntervention, 2013.

Attività editoriali e pubblicazioni

È Reviewer di riviste cardiologiche internazionali e nazionali (G Ital di Cardiologia, J Cardiovasc Medicine, International J Cardiology, Cathet Cardiovasc Interv, Cephalalgia, Circulation Cardiovasc Interventions)

Membro di Editorial Board: J Endovasc Therapy (2010-2013); Journal of Hypertension and Immunotherapy

È autrice e coautrice di 518 pubblicazioni (114 lavori per esteso, 400 abstracts, 4 capitoli di libro) su riviste nazionali ed internazionali, tra cui:

  1. D. Trabattoni, A. Bartorelli, P.Montorsi, F. Fabbiocchi, A. Loaldi, S. Galli, P. Ravagnani, S. Cozzi, L. Grancini, A. Liverani, M.E. Leon, C. Robertson, P. Boyle. Comparison of outcomes in women and men treated with coronary stent implantation. Cathet Cardiovasc Intervent, 2003; 58:20-28.                                                                                                                  
  2. D. Trabattoni, F. Fabbiocchi, P. Montorsi, G. Calligaris, S. Galli, P. Ravagnani, S. De Martini, G. Teruzzi, A.L. Bartorelli. Angiographic patterns of in-stent restenosis in men and women. Ital Heart J, 2005; 6 (2).138-142.                                                                                    
  3. D. Trabattoni, AL. Bartorelli, F. Fabbiocchi, P. Montorsi, P. Ravagnani, M. Pepi, F. Celeste, A. Maltagliati, G. Marenzi, W.O’Neill. Hyperoxemic perfusion of left anterior descending coronary artery after primary angioplasty in anterior ST-elevation myocardial infarction. Cathet and Cardiovasc Interv, 2006; 67:859-865. DOI:10.1002/ccd.20704
  4. D. Trabattoni, F. Fabbiocchi, P. Montorsi, P. Ravagnani, S. Galli, G. Teruzzi, G. Calligaris, S. De Martini, AL Bartorelli. Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: analysis of a single center registry. Cath Cardiovasc Interv, 2007; 70 (3): 415-421. DOI 10.1002/ccd.21149                                                                                                                                                  
  5. D. Trabattoni, F. Fabbiocchi, P. Montorsi, S. Galli, G. Teruzzi, L. Grancini, P. Gatto, A.L. Bartorelli. Sustained long-term benefit of PFO closure on migraine. Cath Cardiovasc Interv, 2011; 77 (4):570-574. doi: 10.1002/ccd.22826                                                                                                 
  6. D. Trabattoni, P. Montorsi, F. Fabbiocchi, A. Lualdi, P. Gatto, A.L. Bartorelli. A new kaolin-based haemostatic bandage compared with manual compression for bleeding control after percutaneous coronary procedures. European Radiology, 2011; 21(8):1687-91.  doi: 10.1007/s00330-011-2117-3. Epub 2011 Apr 9.
  7. D. Trabattoni, A. BartorelliIVUS in bifurcation stenting: what have we learned? Eurointervention suppl 2010; 6: J88-J93.  doi: 10.4244/EIJV6SUPJA14                                          
  8. D. Trabattoni, F.Fabbiocchi, S. Galli, P. Montorsi, A. Lualdi, L. Grancini, Ravagnani, A.L. Bartorelli. Sex difference in long-term clinical outcome after sirolimus-eluting stent implantation. Coron Artery Dis, 2011; 22(6):442-6. DOI 10.1097/MCA.0b013e3283475056                       
  9. Taddei S, Trabattoni D. The Symplicity HTN-3 study. G Ital Cardiol. 2014 Sep;15(9):460-4. doi: 10.1714/1640.17968.  
  10. D. Trabattoni, F. Fabbiocchi, P. Olivares, G. Basadonna, G. Calligaris, A. Bartorelli. A kaolin-based hemostatic gauze as an adjunctive tool for bleeding control after vascular closure devices use in TAVI patients. Int J Rec Scient Res, 2015; 6 (3):2919-2921
  11. Bartorelli AL, Trabattoni D, Almonacid A, Fabbiocchi F, Montorsi P, Galli S, Grancini L, Ravagnani P, Mintz GS, Kaplan AV, Popma JJ, Maehara A. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton bifurcation stent in conjunction with an everolimus-eluting stent: IUVANT (intravascular ultrasound evaluation of tryton stent) study. Catheter Cardiovasc Interv. 201585(4):544-53. doi: 10.1002/ccd.25629.
  12. Trabattoni D, Gaspardone A, Sgueglia GA, Fabbiocchi F, Gioffrè G, Montorsi P, Calligaris G, Iamele M, De Santis A, Bartorelli AL. AMPLATZER versus Figulla occluder for transcatheter patent foramen ovale closure. EuroIntervention. 2017;12(17):2092-2099. doi: 10.4244/EIJ-D-15-00499.
  13. Trabattoni D, Fabbiocchi F, Montorsi P, Galli S, Ravagnani P, Calligaris G, Teruzzi G, Grancini L, Troiano S, Ferrari C, Bartorelli AL. A Long-term Single-center Registry of 6,893 Patients Undergoing Elective Percutaneous Coronary Intervention With the Xience Everolimus-Eluting Stent. J Invasive Cardiology, 2019; in press

Riconoscimenti e premi

Fellow della Società Italiana di Cardiologia (1995-present)

Fellow della European Society of Cardiology (Agosto 2001-present)

Membro del Gruppo Italiano di Cardiologia Invasiva (2001-present)

Fellow dell’ American College of Cardiology (Febbraio 2005-present)

Member della European Association of Percutaneous Cardiovascular Interventions (EAPCI) (Settembre 2007-present)

Riceve il premio Rosa Camuna – Regione Lombardia (2009).

Graduation in Medicine at the University of Milan in 1992; board in Cardiology at the University of Milan in 1997.

Visiting fellow in the Intravascular Ultrasound Laboratory, Catheterization Lab, Washington Hospital Center (1997-1998).

In 1998 she becomes staff member of the Cath Lab at the Centro Cardiologico Monzino and Assistant Director in 2014. She is elected Chief of the Invasive Cardiology Unit at the same Institute in October 2017 and Director of the Women Heart Center, she founded in 2017, focused on cardiovascular prevention in women.

Teaching clinical cardiology at the postgraduate cardiology school, University of Milan.

She is elected committee member of the National Superior Institute of Health (ISS) for cardiovascular devices evaluation in 2011 and member of the ISS committee for a ministerial consensus document on gender-based medicine.

Scientific Results

She focuses her research interests in interventional cardiology section, evaluating factors possibly affecting PCI outcomes, according to different coronary devices use. She has studied cardioprotective tools adopted during primary angioplasty as adjunctive therapy for a faster left ventricle function recovery, after acute myocardial infarction.

She has studied potential correlations between patent foramen ovale and migraine and compared different occluder devices in PFO closure.

She actively contributed to the writing of the national consensus document on antiplatelet treatment management in patients with previous coronary stenting addressed to any surgery, by the GISE (Italian Society of Invasive Cardiology).

She has studied safety and efficacy of short-term antiplatelet therapy after drug-eluting and drug-coated stents in high-bleeding risk patients.

Actively working at international collaborative research projects:

  1. Acute and 30-day outcomes in women after TAVR: Results from the WIN-TAVI (Women’s International Transcatheter Aortic Valve Implantation) Real World Registry. JACC Cardiovasc Interv2016;
  2. Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anesthesiological societies.  Eurointervention, 2014;
  3. Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry. EuroIntervention, 2013.

Editorial role and Publications

She is reviewer of national and international cardiology journals (G Ital di Cardiologia, J Cardiovasc Medicine, International J Cardiology, Cathet Cardiovasc Interv, Cephalalgia, Circulation Cardiovasc Interventions).

Editorial Board member: J Endovasc Therapy (2010-2013); Journal of Hypertension and Immunotherapy (2017); BMC Cardiovascular Disorders (2017).

She authored and co-authored 518 papers (114 peer-review manuscripts, 400 abstracts, 4 chapters book) on national and international journals.

Professional Society Membership and awards

Fellow of the Italian Society of Cardiology  (1995-present)

Fellow of the European Society of Cardiology (2001-present)

Member of the Italian Group of Invasive Cardiology  (2001-present)

Fellow of the American College of Cardiology (2005-present)

Member of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) (2007-present)

Rosa Camuna award – by Regione Lombardia (2009)